Piedmont Lithium has received approval from the North Carolina Department of Environmental Quality to develop one of the largest U.S. sources of lithium, a key metal for electric vehicle batteries. Despite opposition from neighbors, the approval removes a major hurdle for the company's plans.
) supplier Piedmont Lithium to develop one of the largest U.S. sources of the key electric vehicle battery metal, although key financing and local regulatory challenges remain.
Shares in the company, which first applied for the permit in August 2021, rose 33% in morning trading. The state has never turned down a mining permit application. The years-long opposition to the project, which would become one of the few lithium-producing sites in the U.S, illustrates broadening tension in the country, as resistance to living near a mine clashes with the potential of EVs to mitigate climate change.
Piedmont Lithium Approval North Carolina Lithium Electric Vehicle Batteries
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
North Carolina approves mining permit for Tesla supplier Piedmont LithiumNo 1 source of global mining news and opinion
Lire la suite »
Sigma Lithium CEO won’t sell the company at current lithium pricesNo 1 source of global mining news and opinion
Lire la suite »
M4E Lithium Secures $7.5M to $10M Funding to Accelerate Brazilian Lithium ExplorationClean Tech News & Views: EVs, Solar Energy, Batteries
Lire la suite »
Sigma Lithium receives letter of arbitration from LG Energy SolutionNo 1 source of global mining news and opinion
Lire la suite »
Ioneer moves closer to Nevada lithium mine approval with start of public reviewNo 1 source of global mining news and opinion
Lire la suite »
New Drug Regimen for Pancreatic Cancer Receives FDA ApprovalA new drug regimen for certain types of pancreatic cancer recently received approval from the U.S. Food and Drug Administration (FDA) — the first new medication in nearly a decade.
Lire la suite »